Trials / Completed
CompletedNCT06121037
Greater Occipital Nerve Pulsed Radiofrequency for the Treatment of Combined Migraine and Cervicogenic Headache (New Approach)
Greater Occipital Nerve Pulsed Radiofrequency for the Treatment of Combined Migraine and Cervicogenic Headache (New Approach): Randomized Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Combined migraine and cervicogenic headache present significant challenges in clinical management due to their complex and overlapping pathophysiologies. Both conditions involve the trigeminocervical complex, suggesting a potential shared anatomical and neurobiological basis
Detailed description
Traditional treatment approaches for these headaches often include pharmacological interventions, but in cases of refractory or inadequate response, interventional techniques targeting the greater occipital nerve (GON) have gained attention. Radiofrequency ablation (RFA) has gained recognition as a potential therapeutic option for patients with refractory combined migraine and cervicogenic headaches. The proximal and distal ultrasound-guided approaches are widely utilized for GON RFA. These approaches aim to disrupt pain signals transmitted by the GON and provide relief of pain for these headache disorders
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | proximal ultrasound-guided GON radiofrequency ablation | proximal GON radiofrequency |
| PROCEDURE | distal ultrasound-guided GON radiofrequency ablation | distal GON radiofrequency |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2023-08-01
- Completion
- 2023-09-01
- First posted
- 2023-11-07
- Last updated
- 2023-11-08
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06121037. Inclusion in this directory is not an endorsement.